Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4−/−: A double-blind, randomized, placebo-controlled crossover trial

MLA

Huizi Li, et al. “Medium-Chain Triglycerides Improved Cognition and Lipid Metabolomics in Mild to Moderate Alzheimer’s Disease Patients with APOE4−/−: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial.” Clinical Nutrition, vol. 39, July 2020, pp. 2092–105. EBSCOhost, https://doi.org/10.1016/j.clnu.2019.10.017.

APA

Huizi Li, Yong Zhang, Yan Li, Xinsheng Zhang, Changyong Xue, Feng Li, Qing Xu, Yang Tao, Rui Mo, Yinghua Liu, Lu Liu, & Bo Zhou. (2020). Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer’s disease patients with APOE4−/−: A double-blind, randomized, placebo-controlled crossover trial. Clinical Nutrition, 39, 2092–2105. https://doi.org/10.1016/j.clnu.2019.10.017

Chicago

Huizi Li, Yong Zhang, Yan Li, Xinsheng Zhang, Changyong Xue, Feng Li, Qing Xu, et al. 2020. “Medium-Chain Triglycerides Improved Cognition and Lipid Metabolomics in Mild to Moderate Alzheimer’s Disease Patients with APOE4−/−: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial.” Clinical Nutrition 39 (July): 2092–2105. doi:10.1016/j.clnu.2019.10.017.